Massachusetts Financial Services’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Buy |
43,544
+538
| +1% | +$6.13K | ﹤0.01% | 849 |
|
|
2025
Q1 | $511K | Sell |
43,006
-24,398
| -36% | -$290K | ﹤0.01% | 847 |
|
|
2024
Q4 | $1.27M | Sell |
67,404
-2,011
| -3% | -$37.9K | ﹤0.01% | 796 |
|
|
2024
Q3 | $1.56M | Sell |
69,415
-28,756
| -29% | -$646K | ﹤0.01% | 755 |
|
|
2024
Q2 | $2.05M | Sell |
98,171
-14,608
| -13% | -$305K | ﹤0.01% | 744 |
|
|
2024
Q1 | $1.66M | Sell |
112,779
-29,367
| -21% | -$432K | ﹤0.01% | 744 |
|
|
2023
Q4 | $1.47M | Buy |
142,146
+101,320
| +248% | +$1.05M | ﹤0.01% | 742 |
|
|
2023
Q3 | $321K | Buy |
40,826
+20,020
| +96% | +$157K | ﹤0.01% | 820 |
|
|
2023
Q2 | $208K | Sell |
20,806
-490
| -2% | -$4.9K | ﹤0.01% | 809 |
|
|
2023
Q1 | $189K | Buy |
+21,296
| New | +$189K | ﹤0.01% | 832 |
|